4//SEC Filing
NEWTON ROGER S 4
Accession 0001179110-18-010995
CIK 0001434868other
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 4:56 PM ET
Size
11.2 KB
Accession
0001179110-18-010995
Insider Transaction Report
Form 4
NEWTON ROGER S
DirectorExecutive Chairman, CSO
Transactions
- Sale
Common Stock
2018-08-27$53.68/sh−700$37,576→ 615,726 total - Sale
Common Stock
2018-08-27$52.91/sh−700$37,037→ 615,026 total - Sale
Common Stock
2018-08-27$51.46/sh−4,200$216,132→ 610,826 total - Sale
Common Stock
2018-08-27$50.65/sh−12,100$612,865→ 598,726 total
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 21, 2018.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.40 to $54.20, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.37 to $53.37, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.21 to $51.86, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.99, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeother
Related Parties
1- filerCIK 0001242612
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 4:56 PM ET
- Size
- 11.2 KB